MesenFlow Technologies Sàrl
Translational solutions.
MesenFlow Technologies will provide the world's first bioimaging platform service dedicated to accelerating drug development and cosmetic testing by using proprietary hi-throughput models of human disease and inflammation. Their mission is to evaluate compound safety, efficacy & mechanism in early discovery, leading to reduced attrition in the clinical phase.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
MesenFlow Technologies Sàrl
Translational solutions.
Website:
www.mesenflow.com/
Headquarter:
Plan-les-Ouates
Foundation Date:
March 2018
Technology:
- Biotech
Sectors:
- Biotech
- Drug development platforms
- Drug discovery
- Imaging and Radiology
- Inflammation
- Research and development
- Services for companies
Support received
